Michael Koeris, PhD

Dr. Michael Koeris serves as Professor of Bioprocessing and is a member of the Amgen Bioprocessing Center in the Department of Biological Engineering and Management. Prior to joining KGI in 2021, Koeris actively started, grew, and exited biotech startups, both as founder and senior leadership member and Board of Directors.

His entrepreneurial career started by spinning out Sample6 from Prof. Jim Collins’ lab (MIT/BU). After multiple fundraising rounds, market entry and growth, the company was recognized by Forbes as one of the 25 hottest AgTech startups in 2017 and was acquired later that year. Koeris also co-founded the nonprofit Biotechstart.org to facilitate the dissemination of successful business models for biotech startups, increase awareness among prospective founders, and help start more biotech companies. In recognition of his commercial and community building influence, he was recognized as the outstanding entrepreneur in life sciences in Massachusetts in 2018.

Koeris’ research and teaching focus on all aspects of CMC for microbiome medicines (bacteria, bacteriophages, and combinations thereof) as well as advanced cell and gene therapy (ACGT) approaches. He principally teaches the curriculum for Master of Engineering in Biopharmaceutical Processing students but overlaps with Master of Business and Science students.

He also sits on the Board of Directors of both non-profit scientific (AddGene) and for-profit companies (Corvium and Xeno Bio). 

Koeris holds a PhD in Biomedical Engineering  from Boston University and Masters and Bachelors degrees in Biochemistry and Biophysics from the Free University of Berlin, Germany.

Engineering Bacteriophage-Based BiosensorsD Brownell, J King, B Caliando, L Sycheva, M KoerisBacteriophages, 37-50 1 2019

Commercialization of Phage Therapeutics: the Value of Intellectual Property and Patents Fabien Palazzoli, Michael Koeris and Shawna McCallin Pages: 663-692. DOI: https://doi.org/10.21775/9781913652517.19

Collins; James J. (Newton, MA),*Koeris; Michael (Natick, MA), Lu; Timothy Kuan-Ta (Charlestown, MA), Chau; Tanguy My (Palo Alto, CA), Stephanopoulos; Gregory (Winchester, MA), Yoon; Christopher Jongsoo (Seoul, KR), Bacteriophage expressing antimicrobial peptides and uses thereof, U.S. Patent 10,676,721, 2015

*Koeris; Michael Sandor (Natick, MA), Shivers; Robert Patrick (Watertown, MA), Brownell; Daniel Robert (Arlington, MA), Holder; Jason Wyatt (Swampscott, MA), Bowers; Jayson Linn (Cambridge, MA), Recombinant phage for listeria detection, U.S. Patent 10,273,460, 2017

*Koeris; Michael Sandor (Natick, MA), Bowers; Jayson L. (Cambridge, MA), Brownell; Daniel Robert (Arlington, MA), Krzymanska-Olejnik; Edyta (Brookline, MA), Shivers; Robert Patrick (Watertown, MA), Cappillino; Michael (Reading, MA), Codon optimized recombinant phage and methods of using same, U..S Patent 10,039,795, 2015

*Koeris; Michael Sandor (Natick, MA), Thomason; Julie (Reading, MA), Cappillino; Michael (Reading, MA), Shivers; Robert Patrick (Watertown, MA), Brownell; Daniel Robert (Arlington, MA), Bowers; Jayson L. (Cambridge, MA), Lu; Timothy Kuan Ta (Charlestown, MA), Krzymanska-Olejnik; Edyta (Brookline, MA), Phage-based bacterial detection assay, U.S. Patent 9,828,625, 2015

*Koeris; Michael Sandor (Natick, MA), Shivers; Robert Patrick (Watertown, MA), Brownell; Daniel Robert (Arlington, MA), Holder; Jason Wyatt (Swampscott, MA), Bowers; Jayson Linn (Cambridge, MA), Methods of making recombinant phage, compositions and articles of manufacture of same for bacterial detection, U.S. Patent 9,340,817, 2014

Lu; Timothy Kuan Ta (Charlestown, MA), *Koeris; Michael Sandor (Natick, MA), Chevalier; Brett Smith (Malden, MA), Holder; Jason Wyatt (Somerville, MA), McKenzie; Gregory John (Arlington, MA), Brownell; Daniel Robert (Arlington, MA), Recombinant phage and methods, U.S. Patent 9,234,227, 2013